Latest Publications

Share:

New HSR Form To Remain In Place Until Further Notice—Update As of February 20, 2026

On February 19, 2026, the United States Court of Appeals for the Fifth Circuit issued an order staying the lower court’s order enjoining the enforcement of the Federal Trade Commission’s (FTC’s) 2024 rule amending the...more

Federal District Court Vacates Expanded HSR Premerger Notification Rule—Key Takeaways

On February 12, 2026, the United States District Court for the Eastern District of Texas vacated the Federal Trade Commission’s (FTC) 2024 rule (the “Final Rule”), amending the Premerger Notification Rules that implement the...more

2026 Increases To HSR Notification Thresholds, Filing Fees, And Interlocking Directorate Thresholds

The Federal Trade Commission (FTC) has announced increases to the notification thresholds and premerger filing fees under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, which requires premerger notification of...more

Global M&A Insights - Dealmaking Momentum Is On The Rise

Welcome to the latest edition of M&A insights, where we explore the forces shaping transactional activity and predict what will drive dealmaking in the year to come....more

U.S. M&A rises sharply as big-ticket transactions return amid favorable policy developments

Following a surge in U.S. M&A in the second half of 2025, hopes for heightened activity in 2026 are high—even with the midterm elections on the horizon. Here we explore the forces we expect to drive markets in the month to...more

HSR in Transition: FY2024 HSR Annual Report Shows Legacy Trends Amid a Changing Environment

The Federal Trade Commission (FTC) and the U.S. Department of Justice Antitrust Division (DOJ) (collectively, the Agencies) recently issued the Hart-Scott-Rodino Annual Report for Fiscal Year 2024 (the Report), covering the...more

Life Sciences and Healthcare Insights

Welcome to our inaugural Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies...more

Antitrust in Life Sciences—Key European Developments for Pharma Companies

From shifts in merger review to significant abuse of dominance fines from the European Commission, we round up the most important recent events in the antitrust space that life sciences companies should be aware of....more

Key considerations for forming and operating a joint venture in the U.S.

Each of these items will help ensure that a U.S.-based joint venture (JV)—especially one in a regulated industry with cross-border aspects—is set up and operated on solid legal, compliance, and tax footing. By diligently...more

The Trump era DOJ and FTC: a return to merger remedies

This new stance, however, does not signal unchecked dealmaking for transacting parties. The Federal Trade Commission (FTC) and Department of Justice (DOJ) are simultaneously emphasizing that robust, evidence-based enforcement...more

Antitrust authorities on high alert for merger control violations

Sanctions for procedural merger control infringements in 2024 did not meet the lofty heights of previous years. But merging parties should not be complacent. The number of infringement decisions increased. The U.S. and China...more

EU Foreign Subsidies Regulation rains down new challenges for M&A

The transaction notification regime under the EU Foreign Subsidies Regulation (FSR) is now over a year old. To date, intervention levels are low. But assessing whether a filing is required, and gathering the extensive...more

Uncertain regulatory climate makes deal protections crucial

Regulatory intervention levels are rising. The concerns of antitrust authorities and foreign investment (FDI) regulators are evolving and can be unpredictable. Allocation of merger control execution risk in deal documents...more

Merger control reviews speed up (at least for straightforward cases)

Speeding up review periods remained a priority for antitrust authorities outside the U.S. They did this through formal rule changes or adjustments in practice. But the increasing complexity of the issues raised by some deals,...more

Stormy skies for tech deals as antitrust scrutiny intensifies

Tech sector deals are seeing rising mortality rates. AI partnerships are moving up the authorities’ agenda for scrutiny and enforcement. Overall, however, antitrust intervention in 2024 once again focused on transport, energy...more

Rising review risk for deals not meeting merger control thresholds

Antitrust authorities continue to make use of powers to scrutinize deals falling below merger control filing thresholds. Many that don’t have that ability, want it. The European Commission (EC) remains the frontrunner in...more

Merger control frustrates more M&A, but are the tides turning?

Antitrust authorities killed more deals in 2024, marking a third year of rising mortality levels. Where prohibition was on the cards, many dealmakers abandoned their transactions rather than staying the course. The U.S....more

Private equity and serial acquisitions continue to feel the antitrust heat

Private equity acquisitions—notably roll-up strategies—continued to face antitrust scrutiny in 2024. As did serial acquisitions by non-PE acquirers. Headwinds were particularly strong in the U.S., but breezes from other...more

Antitrust authorities’ skepticism of merger remedies causes headwinds for dealmakers

The number of deals cleared with conditions fell sharply in 2024. Many antitrust authorities remained skeptical of whether merger remedies can effectively address antitrust concerns, choosing instead to challenge and...more

Global trends in merger control enforcement report- 2025

Merger control and foreign investment hurdles contributed to a challenging 2024 for M&A. 2025 looks more promising, with pro-business agendas and regulatory easing in key jurisdictions expected to fuel a surge in dealmaking...more

2025 increases to HSR notification thresholds, filing fees, interlocking directorate thresholds, and HSR penalties

The Federal Trade Commission (FTC) has announced increases to the notification thresholds and premerger filing fees under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, which requires premerger notification of...more

FTC secures record USD5.68 million gun-jumping penalty

On January 7, 2025, the U.S. Federal Trade Commission announced a record USD5.68m civil penalty to settle alleged pre-merger coordination in violation of the HSR Act. This settlement is the largest dollar penalty that has...more

How will the Trump administration impact M&A?

M&A practitioners anticipate a ‘Trump bump’ - The scale of Donald Trump’s victory in the presidential election – and the fact the Republicans now have full control of Congress – has been greeted with optimism by U.S....more

90 Results
 / 
View per page
Page: of 4

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide